20 December 2013

Cancer Immunotherapy Tops AAAS and Science's Top 10 Breakthroughs of 2013

Science, the peer-reviewed general-science journal, and its publisher, the American Association for the Advancement of Science (AAAS) released their annual list of groundbreaking scientific achievements for 2013.

Number one on the list is the study on cancer immunotherapy.

The editors of Science believe that the strong promise that cancer immunotherapy brings in treating and combating the deadly disease is worthy enough to get the top spot in 2014's most important science breakthrough.

Last year, the discovery of the Higgs Particle was chosen as the scientific breakthrough of the Year for 2012.

Immunotherapy involves inducing, enhancing, or suppressing an immune response to combat a disease. There are two ways; Activation and Suppression. Activation Immunotherapy is designed to elicit or amplify the immune system to respond to the disease. Suppression Immunotherapy reduces or suppresses the disease.

Some of the other breakthroughs in the list include:
  • CRISPR (Clustered Regularly Interspaced Short Palindromic Repeat) which is a gene editing technique that is used it to manipulate the genomes of various plant, animal and human cells.
  • A new type of solar-cell materials called Perovskite solar cells which are cheaper and easier to produce than those in traditional silicon cells.
  • The discovery that cosmic rays come from supernova remnants
The full top ten scientific breakthroughs for 2013 are listed below.

Science's Top 10 Breakthroughs of 2013

The cancer research community experienced a sea change in 2013 as a strategy, decades in the making, finally cemented its potential. Promising results emerged from clinical trials of cancer immunotherapy, in which treatments target the body's immune system rather than tumors directly. The new treatments push T cells and other immune cells to combat cancer—and the editors of Science believe that such approaches are now displaying enough promise to top their list of the year's most important scientific breakthroughs.

This annual list of groundbreaking scientific achievements, selected by Science and its international nonprofit publisher, AAAS, also includes major breakthroughs in solar cell technologies, genome-editing techniques and vaccine design strategies, to name a few. The top-10 list appears in the 20 December issue of the journal along with a related news feature and a multimedia component.

Cancer immunotherapy clinched the #1 spot on the list because, although its ultimate impact on the disease is unknown, recent results are highlighting its success so far.

"This year there was no mistaking the immense promise of cancer immunotherapy," said Tim Appenzeller, chief news editor of the journal Science. "So far, this strategy of harnessing the immune system to attack tumors works only for some cancers and a few patients, so it's important not to overstate the immediate benefits. But many cancer specialists are convinced that they are seeing the birth of an important new paradigm for cancer treatment."

Many of today's advances in cancer immunotherapy can be traced back to the late 1980's, when French researchers identified a receptor on T cells, called CTLA-4. James Allison discovered that this receptor prevented T cells from attacking invaders with their full force. In the mid-1990's Allison showed that blocking CTLA-4 in mice could unleash T cells against tumor cells in the animals, shrinking them dramatically.

Video: AAAS Science Breakthrough of the Year 2013

In the meantime, Japanese researchers identified another "brake" on T cells known as PD-1. Clinical trials involving this receptor began in 2006, and preliminary results in small groups of patients appear to be promising.

Another area of interest involves genetically modifying T cells to make them target tumors. In 2011 this strategy, known as chimeric antigen therapy, or CAR therapy, electrified the cancer research field, and it's now the subject of numerous clinical trials, particularly in blood cancers.

Accordingly, many pharmaceutical companies that wanted nothing to do with immunotherapy several years ago are now investing heavily.

There's still lots of uncertainty regarding how many patients will benefit from these therapies, most of which remain experimental—and for which forms of cancer they will work best. Scientists are busy trying to identify biomarkers that might offer answers, and thinking of ways to make treatments more potent. But a new chapter in cancer research and treatment has begun and the journal Science acknowledges this fact by recognizing cancer immunotherapy as the most significant scientific breakthrough of 2013.

The journal's list of nine other groundbreaking scientific achievements from the past year follows.

CRISPR: This gene-editing technique was discovered in bacteria, but researchers now wield it as a scalpel for surgery on individual genes. Its popularity soared this year as more than a dozen teams of researchers used it to manipulate the genomes of various plant, animal and human cells.

Perovskite Solar Cells: A new generation of solar-cell materials, cheaper and easier to produce than those in traditional silicon cells, garnered plenty of attention this past year. Perovskite cells are not as efficient as commercial solar cells yet, but they are improving very quickly.

Structural Biology Guides Vaccine Design: This year, researchers used the structure of an antibody to design an immunogen—the main ingredient of a vaccine—for a childhood virus that hospitalizes millions each year. It was the first time that structural biology led to such a powerful tool for fighting disease.

CLARITY: This imaging technique, which renders brain tissue transparent and puts neurons (as well as other brain cells) on full display, changed the way that researchers look at this intricate organ in 2013.

Mini-Organs: Researchers made remarkable progress growing mini human-like "organoids" in vitro this year. These included liver buds, mini-kidneys and tiny brains. Such miniaturized human organs may prove to be much better models of human disease than animals.

Cosmic Rays Traced to Supernova Remnants: Although originally detected 100 years ago, scientists haven't been sure where the high-energy particles from outer space known as cosmic rays come from. This year, they finally tied the rays to debris clouds left by supernovae, or exploding stars.

Human Cloned Embryos: Researchers were able to derive stem cells from cloned human embryos this year after realizing that caffeine plays an important role in the process, stabilizing key molecules in delicate human egg cells.

Why We Sleep: Studies with mice showed that the brain cleans itself—by expanding channels between neurons and allowing more cerebrospinal fluid to flow through—much more efficiently during sleep. The finding suggests that restoration and repair are among the primary purposes of catching Z's.

Our Microbes, Our Health: Research on the trillions of bacterial cells that call the human body home made it clear how much these microbes do for us. "Personalized" medicine will need to take these microbial tenants into account in order to be effective.


American Association for the Advancement of Science
Science's 2013 Breakthrough of the Year
Discovery of Higgs Particle Chosen As Scientific Breakthrough of the Year by the AAAS
Science's Breakthrough of the Year: HIV treatment as prevention
2012 In Science: One Year of ScienceShots Images
AAAS News: Letter on Resuming Avian Flu Transmission Research
Quantum Day Top 10 Most Read Articles For 2012
Data Paper on Antarctic Macrobenthic Biodiversity Publicly Available
2012 is the Year of CERN: Highlights, Discoveries and Breakthroughs in Science
How the Hippies Saved Physics, A Book About California Physicists in the 1970s Is Physics World's Book of the Year
The Importance of Maintaining an Unbiased and Accurate View In Online Science and Technology Reporting
Wired Science Presents Best Space Photos of 2012
Decay: Physicists At CERN Make Zombie Movie Filmed At The Large Hadron Collider (LHC)